Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker-guided antibiotic and corticosteroid use in COPD exacerbations
2009-014408-71Phase 4Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Aug 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Change in number of exacerbations treated with corticosteroids. Started Aug 2009; status: completed.
02
Drugs
prednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-014408-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014408-71.